CLINICAL_TRIALS
trial_result
· 2019-02-11
Clinical Trial Update: Specific Use-result Surveillance of Spiriva Respimat in Asthmatics
Summary
A completed post-market surveillance study assessing tiotropium (Spiriva Respimat) use in asthmatics, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Asthma | Status: COMPLETED | Results posted: 2019-02-11